Starting the Treatment Semaglutide is typically prescribed by a healthcare provider after a thorough assessment of your health status and weight loss needs
The patient must receive the shots at the same time during each appointment
Starting July 1, 2026, Medicare will cover FDA-approved weight-loss medications like Wegovy (semaglutide) and Zepbound (tirzepatide) for a flat $50 per month through a new initiative called the Medicare GLP-1 Bridge Program
Some researchers combine it with GHRP-6 to get both elevated baseline GH (from the DAC version) and sharp pulsatile bursts (from GHRP-6)
For Wegovy, patients are eligible if they have a body mass index, or BMI, at or over 27
So it is not, strictly speaking, a use by date (UBD) which is the date beyond which a product should not be consumed in order to avoid any risk to health